Akili Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2024 to a ratio of 8.03, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Akili Inc in Mar 31 2024 quarter, has decreased to 45 days, compared to 48 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 169 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 1579 to 1598.

What is Receivable Turnover Ratio?
What is Akili Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKLI Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	193.88 %	631.71 %	1373.33 %	-	-
Y / Y Revenue Change	238.94 %	574.77 %	756.1 %	78.13 %	71.21 %
Receivable Turnover Ratio (TTM)	8.03	7.67	6.75	8.24	12.33
AKLI's Total Ranking	# 1598	# 1579	# 3826	# 1110	# 0
Accounts Receivable average collection period days	45	48	54	44	30
Seq. Receivable Change	-52 %	-32.13 %	426.19 %	71.43 %	19.51 %
Seq. Revenue Change	-48.87 %	6.7 %	515.79 %	0.88 %	1.8 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 51
Healthcare Sector	# 170
Overall Market	# 1598

Receivable Turnover Ratio Statistics
High	Average	Low
10.78	8.52	7.6
(Jun 30 2023)		(Sep 30 2023)

AKLI Company Profile • Back to AKLI Efficiency Comparisons • Compare AKLI Receivables Turnover Ratio to its Competitors

Financial Statements
Akili Inc 's Accounts Receivable	$ 0 Millions	Visit AKLI's Balance sheet
Akili Inc 's Sales TTM	$ 2 Millions	Visit AKLI's Income Statement
Sources of AKLI's Revenues		Visit AKLI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AKLI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AKLI's Growth Rates	AKLI's Roa	AKLI's Inventory Turnover Ratio	AKLI's Dividend Comparisons
AKLI's Profitability Ratios	AKLI's Roi	AKLI's Asset Turnover Ratio	AKLI's Dividend Growth
AKLI's Valuation Ratios	AKLI's Roe	AKLI's Financial Strength Ratios	AKLI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Cano Health Inc	36.41	$ 2,955.274 Millions	$ 81.171 Millions
Electrocore Inc	35.44	$ 17.889 Millions	$ 0.505 Millions
Lifemd Inc	34.57	$ 161.635 Millions	$ 4.675 Millions
Invo Fertility Inc	33.38	$ 4.249 Millions	$ 0.127 Millions
Prothena Corporation Public Limited Company	32.93	$ 89.251 Millions	$ 2.710 Millions
23andme Holding Co	32.38	$ 219.377 Millions	$ 6.776 Millions
Sonida Senior Living Inc	30.60	$ 260.687 Millions	$ 8.518 Millions
Plus Therapeutics Inc	30.08	$ 6.084 Millions	$ 0.202 Millions
Neuroone Medical Technologies Corp	26.83	$ 3.727 Millions	$ 0.139 Millions
Cv Sciences Inc	26.71	$ 14.790 Millions	$ 0.554 Millions
National Vision Holdings Inc	26.61	$ 2,106.622 Millions	$ 79.168 Millions
Vireo Growth Inc.	26.52	$ 93.132 Millions	$ 3.511 Millions
Ainos Inc	26.44	$ 0.094 Millions	$ 0.004 Millions
Clearside Biomedical Inc	25.87	$ 8.452 Millions	$ 0.327 Millions
Inmed Pharmaceuticals Inc	25.66	$ 6.218 Millions	$ 0.242 Millions
Cytomx Therapeutics Inc	22.78	$ 119.178 Millions	$ 5.233 Millions
Agenus Inc	22.51	$ 161.417 Millions	$ 7.171 Millions
U S Physical Therapy Inc	22.47	$ 611.968 Millions	$ 27.240 Millions
Innovage Holding Corp	22.22	$ 741.328 Millions	$ 33.362 Millions
Bespoke Extracts Inc	21.68	$ 0.957 Millions	$ 0.044 Millions
Kymera Therapeutics Inc	21.18	$ 79.413 Millions	$ 3.750 Millions
Orchestra Biomed Holdings Inc	20.96	$ 2.216 Millions	$ 0.106 Millions
Ginkgo Bioworks Holdings Inc	19.85	$ 208.697 Millions	$ 10.516 Millions
Zivo Bioscience Inc	19.47	$ 0.063 Millions	$ 0.003 Millions
Lineage Cell Therapeutics Inc	18.86	$ 8.003 Millions	$ 0.424 Millions
Scorpius Holdings inc	18.69	$ 9.743 Millions	$ 0.521 Millions
Sab Biotherapeutics Inc	18.68	$ 2.602 Millions	$ 0.139 Millions
Kiniksa Pharmaceuticals International Plc	18.58	$ 301.772 Millions	$ 16.238 Millions
Hookipa Pharma inc	18.38	$ 53.552 Millions	$ 2.913 Millions
Editas Medicine Inc	18.34	$ 69.407 Millions	$ 3.785 Millions

Date modified: 2026-09-08T15:11:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.